The BioTherapeutics master's specialisation focuses on research-oriented education into the development of state-of-the-art therapies using novel biologics, such as vaccines, therapeutic proteins and peptides, and gene therapy products for inflammatory diseases, including atherosclerosis and skin disease. Integration of experimental in-vitro and in-vivo data is aimed to aid a smoother and speedier transition from preclinical research to pharmacological interventions, and the delivery of drugs in the human body. If you are interested in research training in specific drug delivery techniques, and the development of new therapeutic approaches to treat immune-based disorders, such as atherosclerosis, metabolic disorders and inflammatory skin diseases, this master's programme is the right choice.